Ancora Family Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$224K Buy
10,750
+2,500
+30% +$62K 0.08% 193
2016
Q2
$222K Buy
8,250
+400
+5% +$11K 0.08% 174
2016
Q1
$213K Hold
7,850
0.09% 166
2015
Q4
$228K Hold
7,850
0.1% 164
2015
Q3
$213K Buy
+7,850
New +$222K 0.09% 177

Other funds holding NVO

Ancora Family Wealth Advisors's NVO Position: Q3 2016 in Review

Ancora Family Wealth Advisors increased its Novo Nordisk (NVO) stake by 30% in Q3 2016, buying an estimated $62K and bringing the position to 10,750 shares worth $224K. The position accounts for 0.08% of the portfolio, ranked #193.

Ancora Family Wealth Advisors first reported a position in NVO in Q3 2015 and has held it in 5 quarters since. The position peaked at $228K in Q4 2015. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Ancora Family Wealth Advisors held 10,750 shares of Novo Nordisk worth $224K as of Q3 2016.
  • Ancora Family Wealth Advisors bought 2,500 Novo Nordisk shares in Q3 2016, an estimated $62K.
  • Novo Nordisk made up 0.08% of Ancora Family Wealth Advisors's portfolio in Q3 2016, its #193 holding.
  • Ancora Family Wealth Advisors first reported a position in Novo Nordisk in Q3 2015 and has held it in 5 quarters since.
  • Ancora Family Wealth Advisors's Novo Nordisk position peaked at $228K in Q4 2015.
  • 513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Ancora Family Wealth Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.